Article info
PDFUnexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Use of cabergoline for the management of persistent Cushing’s disease in pregnancy
- Correspondence to Dr Kathleen Su-Yen Sek, kathleen_sy_sek{at}nuhs.edu.sg
Citation
Use of cabergoline for the management of persistent Cushing’s disease in pregnancy
Publication history
- Accepted June 16, 2017
- First published July 14, 2017.
Online issue publication
January 30, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.